Xoma Pharmaceuticals

Xoma (pronounced “zoma”): the most important Petrochem subsidiary, responsible for drug development and production. A world leader in new pharmaceuticals (vaccines and therapies for, among other things, AIDS, schizophrenia and cyberpsychosis), with tightened security and a dark reputation (CP3161 p.18-19). It is also the maker of the stimulant Catch-22 (CP3271 p.75).

Key facts

  • Joint programs with Biotechnica: genetic drugs, bacteria and viruses made to order (CP3161 p.19).
  • Accused of spreading designer drugs and plagues; no case has gone to court (CP3161 p.19).
  • Runs vaccination drives in poor neighborhoods, where it secretly tests designer drugs and plagues; promotes animal welfare to hide experiments (CP3161 p.27).
  • Guards: black coveralls, SP 20 vests, helmets with dark visors; Colt Enforcement 10, MustangArms ARS-5C or MustangArms Raider; hired separately and trained by Arasaka Security (CP3161 p.29).
  • Headquarters: Xoma Pharmaceuticals Headquarters in South Night City (where the company was founded) (CP3161 p.37).
  • Cross-holds 6.2% of Petrochem’s shares, while itself being 100% owned by it (CP3161 p.41).
  • Products: Paracaine, Priapan Spray (CP3161 p.33-34).
  • Xoma Pharmaceutical is the maker and brand owner of the stimulant Catch-22. (CP3271 p.75)

Relations

Sources

  • CP3161: Cyberpunk 2020 - Corporation Report 2020 - Corpbook 3 - Petrochem & Sovoil (1992), PDF p. 18-19, 27, 29, 33-34, 37, 41
  • CP3271: Cyberpunk 2020 - Wildside (1993), PDF p. 75